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Imidazoacridinone-dependent lysosomal
photodestruction: a pharmacological Trojan horse
approach to eradicate multidrug-resistant cancers
Y Adar1, M Stark1, EE Bram1,6, P Nowak-Sliwinska2,3, H van den Bergh2, G Szewczyk4, T Sarna4, A Skladanowski5, AW Griffioen3
and YG Assaraf*,1
Multidrug resistance (MDR) remains a primary hindrance to curative cancer therapy. Thus, introduction of novel strategies
to overcome MDR is of paramount therapeutic significance. Sequestration of chemotherapeutics in lysosomes is an established
mechanism of drug resistance. Here, we show that MDR cells display a marked increase in lysosome number. We further
demonstrate that imidazoacridinones (IAs), which are cytotoxic fluorochromes, undergo a dramatic compartmentalization in
lysosomes because of their hydrophobic weak base nature. We hence developed a novel photoactivation-based
pharmacological Trojan horse approach to target and eradicate MDR cancer cells based on photo-rupture of IA-loaded
lysosomes and tumor cell lysis via formation of reactive oxygen species. Illumination of IA-loaded cells resulted in lysosomal
photodestruction and restoration of parental cell drug sensitivity. Lysosomal photodestruction of MDR cells overexpressing the
key MDR efflux transporters ABCG2, ABCB1 or ABCC1 resulted in 10- to 52-fold lower IC50 values of various IAs, thereby
restoring parental cell sensitivity. Finally, in vivo application of this photodynamic therapy strategy after i.v. injection of IAs in
human ovarian tumor xenografts in the chorioallantoic membrane model revealed selective destruction of tumors and their
associated vasculature. These findings identify lysosomal sequestration of IAs as an Achilles heel of MDR cells that can be
harnessed to eradicate MDR tumor cells via lysosomal photodestruction.
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Imidazoacridinones (IAs; Supplementary Figure 1) are hydro-
phobic weak base cytotoxic fluorochromes that display
considerable antitumor activity towards murine and human
malignant cell lines in vitro,1 and against breast- and
colon adenocarcinomas in vivo.2 The marked similarity in
the chemical structure between IAs and the established
topoisomerase II inhibitormitoxantrone, suggested a common
cellular drug target. Indeed, previous studies have shown
that IAs block topoisomerase II activity1 and stimulated
the in vitro formation of topoisomerase II-cleavable com-
plexes. Moreover, previous studies have shown that
IAs, which harbor a planar IA core, are capable of DNA
intercalation.3
The frequent emergence of multidrug resistance (MDR) to
structurally and functionally unrelated anticancer drugs,
is a major impediment to curative cancer chemotherapy.4–9
ATP-driven MDR efflux transporters belong to the large
ATP-binding cassette (ABC) superfamily of transporters that
include ABCB1 (P-gp), ABCC1 (MRP1) and ABCG2 (BCRP).
Overexpression of these efflux pumps results in the expulsion
of a multitude of chemotherapeutic drugs, thereby leading to
acquisition of a broad-spectrum drug resistance phenotype
known as MDR. As MDR remains a major obstacle to
successful cancer chemotherapy, there is a burning need to
develop new strategies to overcome MDR phenomena.
Taking advantage of the increased number of lysosomes in
MDR cells, we here developed an IAs-based photoactivated
pharmacological Trojan horse approach to eliminate MDR
cancer cells in vitro and in vivo. This strategy is based on the
efficient sequestration of IAs in lysosomes. Upon photoactiva-
tion, reactive oxygen species (ROS) rapidly form, resulting in
lysosomal rupture and tumor cell lysis. In vivo photodynamic
therapy (PDT) experiments, based on the selective photo-
destruction of targeted tissue10 further established that this
strategy is endowed with a potent capability to destroy human
tumor xenografts and their associated vasculature.
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Results
IAs specifically accumulate in lysosomes. Recently we
have shown that IAs (Supplementary Figure 1), including
C-1330, C-1375 and C-1379, are not recognized by ABCG2,
whereas their hydroxyl-containing homologs (e.g., C-1311)
are readily expelled by this multidrug efflux pump.11 Hence,
on the basis of their hydrophobic weak base nature and their
structural similarity to acridine orange, an established
fluorophore known to concentrate within lysosomes, we
hypothesized that these IAs may also accumulate within
acidic organelles such as lysosomes. We therefore exposed
parental A549 cells and their ABCG2-overexpressing
MDR subline A549/K1.511 to C-1330 (green fluorescence)
and LysoTracker red (red fluorescence), an established
viable lysosomal marker. Cells were counterstained with the
supravital dye Hoechst 33342 (blue fluorescence). Both cells
displayed co-localization of the red and green fluorescence,
resulting in an orange signal in the merged photographs
(Figures 1a–f). Identical results were obtained with the IAs
C-1375 and C-1379 (data not shown). Moreover, we
observed a sevenfold increase in lysosomes’ fluorescence
(i.e., an increase in the number and volume of lysosomes)
in MDR A549/K1.5 cells (4500±937a.u./cell), relative
to parental A549 cells (600±317a.u./cell) as determined
by LysoTracker red staining and quantification using the
EZ-Quant software (EZ-Quant, Tel-Aviv, Israel) (Figure 1g).
Viable staining of the mitochondrial marker MitoTracker red
(red fluorescence) in A549 cells excluded the possibility of
C-1330 localization in mitochondria (Supplementary Figure 2).
We postulated that the acidic pH of lysosomes is the driving
force for the marked compartmentalization of IAs in lysosomes.
We hence used two independent approaches to alkalinize
lysosomes: ammonium chloride, a weak base lysosomotropic
alkalinization agent and bafilomycin A1, a potent inhibitor of
Hþ -ATPase (i.e., vesicular ATPase). Following preincubation
of A549 (Figures 2a, c and e) andA549/K1.5 cells (Figures 2b, d
and f) with ammoniumchloride (Figures 2c and d) or bafilomycin
A1 (Figures 2e and f), subsequent exposure to C-1330 did not
result in lysosomal accumulation of C-1330. Interestingly, under
these conditions, C-1330, which bears a planar acridone ring
structure that is typical of various DNA dyes, brightly stained the
nuclei of both A549 and A549/K1.5 cells, in agreement with
previous studies.3,11
Photosensitization of C-1330-treated cells results in rapid
lysosomal destruction mediated by ROS. Switching on the
light of the fluorescence microscope resulted in a rapid
destruction and disappearance of fluorescent lysosomes in
C-1330-treated cells (Supplementary Movies 1 and 2). These
lysosomal bursts were visible as multiple asynchronous
flashes in both A549 and A549/K1.5 cells and resulted in the
disappearance of all fluorescent lysosomes over a period of a
few minutes at the applied conditions. The disappearance of
lysosomes was accompanied by a simultaneous gradual
increase in nuclear fluorescence. We hypothesized that the
rapid rupture of lysosomes and consequent release of C-1330
was due to an intrinsic photosensitizing activity of C-1330.
Photosensitizers have their destructive activity often through
the formation of ROS, which may be responsible for lysosomal
membrane lysis. Using direct detection of the luminescence
centered at 1270nm, we measured the generation of singlet
oxygen using C-1375 and C-1379 after pulsed excitation with
355nm laser radiation in acetonitrile and DMSO (Supplementary
Figure 3A). Measurable luminescence with lifetime of the order of
3ms was only detected in samples that were saturated with either
oxygen or air. The lifetime of the luminescence was consistent
with the reported lifetime of singlet oxygen in this solvent.12
Moreover, using electron paramagnetic resonance (EPR)-spin
trapping and 5,5-dimethyl-1-pyrroline N-oxide (DMPO) as a spin
trap, we observed photogeneration of superoxide anion by both
Figure 1 Co-localization of C-1330 and LysoTracker red in lysosomes in A549
and A549/K1.5 cells. Parental A549 (a–c) and their MDR subline A549/K1.5 (d–f)
were viably stained with Hoechst 33342 (blue nuclear fluorescence) along with
either 100 nM LysoTracker red for 1 h (red fluorescence; a, and d) or 10mM C-1330
(green fluorescence; b, and e) for 30 min. Viable cell staining and quantification of
the number of red fluorescent lysosomes per cell were carried out by first staining
with 100 nM LysoTracker red for 1 h (g) followed by lysosome counting in at least 25
cells from each of three independent experiments using the EZ-Quant software.
Inverted fluorescence microscopy analysis of viable cell staining was performed at a
magnification of  630
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C-1375 and C-1379 in a mixture of DMSO and H2O (9:1);
Supplementary Figure 3B shows the EPR spectra of the DMPO
spin adduct that evolved with irradiation of the samples in the
resonant cavity. The EPR signal of the DMPO spin adduct
became much stronger in the presence of 1mM NADH.
Simulation of the EPR signal using magnetic parameters
commonly used for the DMPO-OOH adduct, is fully consistent
with the generation and spin trapping of superoxide anion. The
accumulation of DMPO-OOH with irradiation time for C-1375
and C-1379 in the absence or presence of NADH is shown in
Supplementary Figures 3A and B respectively. Whereas, the
accumulation of DMPO-OOH with irradiation time for riboflavin
was determined in the presence of EDTA (Supplementary
Figures 3B). From such data one can calculate relative rates of
the spin adduct formation in samples of the studied compounds
in comparison with riboflavin/EDTA, which is a known generator
of superoxide anion. It is evident from these results that these
IAs can generate singlet oxygen and superoxide anion upon
photoexcitation, particularly in the presence of an electron donor
such as NADH. Due to the ability of superoxide anion to
dismutate, it can be postulated that hydrogen peroxide will also
be generated after photoexcitation of IAs. These results suggest
that IAs-dependent lysosomal photodestruction is mediated by
the generation of ROS, which presumably leads to the rapid
rupture of the lysosomal membrane.
Photosensitization markedly enhances the cytotoxic
effect of IAs and overcomes MDR. We next explored the
impact of photosensitization of C-1330-loaded lysosomes on
cell viability. Monolayers of A549 and A549/K1.5 cells
(Figures 3a and b, respectively) were first incubated with
C-1330, washed with drug-free medium, subjected to light
from the fluorescence microscope and further incubated
for 48 h. Light microscopy of Crystal Violet-stained cells
revealed that cells in light-exposed areas were completely
lysed. On the basis of these results and based on the
markedly increased number of lysosomes per ABCG2-
overexpressing MDR A549/K1.5 cell, we further explored
the hypothesis that MDR cells may consequently become
highly sensitive to the cytotoxic effect elicited by IAs upon
lysosomal photodestruction, resulting in the overcoming of
MDR. To this end, we first determined the cytotoxic activity of
C-1330 in A549 and A549/K1.5 cells (Figures 3c and d,
respectively) in the presence or absence of photo-
sensitization. Illumination of C-1330-loaded cells resulted
in a 6- and 14-fold decrease in the IC50 values in A549
and A549/K1.5 cells, thereby resulting in an equal
C-1330 sensitivity in both cell lines (Table 1).
We expanded these findings to other IAs; photosensitiza-
tion markedly enhanced the cytotoxic activity of C-1375 and
C-1379 in A549 and A549/K1.5 cells by 10–32-fold, relative to
nonilluminated cells (Table 1). These results prompted us to
further expand the scope of the cytotoxic impact of IAs upon
photoexcitation to ABCB1 (P-gp)-overexpressing MDR non-
small-cell lung cancer SW1573/2R160 cells and ABCC1
(MRP1)-overexpressing ovarian carcinoma 2008/MRP1
cells (Table 1). Photosensitization of C-1375-loaded MDR
SW/2R160 and 2008/MRP1 cells resulted in a 13–51-fold
decrease in the IC50 of C-1375, whereas their parental cells
were sensitized by factors of 24–36-fold. Remarkably, in the
absence of illumination, these MDR cells displayed IC50
values in the range of 3.3–5.5 mM, whereas photosensitization
decreased the IC50 values to as low as 90–330nM; we thus
achieved a significant increase in parental cell sensitivity in
three different types of MDR cancer cells.
To further strengthen the current finding that cell death
occurs via lysosomal photodestruction we also evaluated the
cytokskeletal structure of cells before or after lysosomal
photodestruction by following F-actin using the well-estab-
lished Texas Red-Phalloidin conjugate (Figures 3e and f).
Phalloidin is a bicyclic peptide belonging to a family of toxins
isolated from the deadly Amanita phalloides and is widely
used in fluorescence imaging applications to selectively label
F-actin. Importantly, incubation with C-1330 followed by
illumination led to lysosomal photodestruction, which resulted
in highly damaged cells that were devoid of their cytoplasmic
content as well as their actin cytoskeleton and only showed
deformed residual cytoskeletal structure that was present in
the cell’s perimeter (Figure 3f). In contrast, cells exposed to
C-1330 in the absence of illumination retained a normal actin
cytoskeleton (Figure 3e).
Figure 2 Lysosomotropic alkalinization agents abolish intralysosomal accumu-
lation of C-1330. A549 (a, c and e) and A549/K1.5 cells (b, d and f) were
preincubated either with the lysosomotropic agent ammonium chloride (10 mM) for
30 min (c and d), with bafilomycin A1 (1mM) for 1 h (e and f) or with none (a and b),
following which cells were further incubated for 30 additional min with C-1330
(10mM). Cells were then analyzed by fluorescence microscopy at a magnification of
 630
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Chloroquine induces a marked increase in both the
number and volume of lysosomes resulting in enhanced
C-1330 cytotoxicity upon photosensitization. Given the
remarkable cytotoxicity elicited by various IAs on tumor cells,
we explored the possibility of enhancing the number and
volume of lysosomes in tumor cells. Previously it was shown
that chloroquine, an anti-malarial and lysosomotropic agent,
increased the number and volume of lysosomes in tumor
Figure 3 Photoexcitation of C-1330-loaded A549 and A549/K1.5 cells. Crystal Violet staining of C-1330-loaded cells was followed by exposure to confined blue light. A549
(a) and A549/K1.5 (b) cells were grown to half confluence and loaded with 10 mM C-1330 for 1 h. Under the light microscope, a confined zone of the cell monolayers was
exposed for 1 min to a pulsed blue light beam (lex¼ 470 nm with a measured fluence ofB180 W/m2). After 48 h, monolayers were fixed with methanol, stained with Crystal
Violet and analyzed by light microscopy at an  8 magnification. Cellular growth inhibition by C-1330 was determined as follows: logarithmically growing A549 cells (c) and
their MDR A549/K1.5 subline (d) were exposed to various concentrations of C-1330 for 2 h. To evaluate the effect of illumination on the cytotoxicity of C-1330, cells were
divided into illuminated (1 h constant illumination which yielded a total fluence of 5 J/cm2) and nonilluminated control cells. Cellular viability was determined using a Cell
Proliferation Kit (XTT). Values depicted represent means±S.D. of at least three independent experiments. The F-actin cytoskeleton was evaluated with Texas Red-X-
Phalloidin in monolayer A549 cells; following 30 min incubation with 10 mM C-1330 without illumination (e) or 2 h after photosensitzation (f), cells were incubated with Texas
Red-X-Phalloidin and the cytoskeleton was analyzed by a fluorescence microscope as detailed in Materials and Methods. Note the highly damaged hollow cells that lost the
cytoplasmic cytoskeletal structure due to lysosomal photodestruction after incubation with C-1330 and illumination, whereas cells incubated with C-1330 in the absence of
illumination retained their intact cytoskeleton
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cells.13 Fluorescence microscopy analysis after staining with
LysoTracker red revealed that exposure of A549 cells to
20mM chloroquine for 24 (compare Figure 4c with 4a) or 48 h
(compare Figure 4e with 4a) resulted in a marked dose-
dependent increase in the number and volume of lysosomes
(Figure 4g); quantification using EZ-Quant software revealed
an increase of 8.4- and 21.7-fold, respectively, in lysosomal
fluorescence as compared with untreated control cells. We
hence explored the impact of chloroquine pretreatment on
C-1330 sensitivity in the presence and the absence of light
exposure by growth inhibition assays. Consistent with the
increased number and volume of lysosomes, chloroquine
induced a marked time- and dose-dependent resistance of
parental A549 cells to C-1330, in the absence of
photosensitization; upon illumination, cells became 23- to 49-
fold more sensitive to C-1330, compared with the 6-fold photo-
sensitization in the absence of chloroquine (Supplementary
Table 1). These results indicate that chloroquine, currently used
to treat malaria and rheumatoid arthritis, may be applied to
increase the number and volume of lysosomes following which
tumor cells may be efficiently eradicated by photosensitization
of IA-loaded lysosomes.
In vivo antitumor activity of IAs using tumor
xenografts. C-1375 and C-1379 showed similar
spectroscopic characteristics with absorbance in the range
340–500nm; their normalized fluorescence spectra
are shown in Figure 5a. Both IAs emitted an intense
fluorescence when excited at 444 nm with maximal
emission at 553–554nm. Intravenous injection of these IAs
into the chicken CAM model, followed by photosensitization
produced a photodynamic vaso-occlusive activity for both
compounds. When injected at a low dose (1mg/embryo;
Figure 5b), the capillary network was massively occluded,
whereas larger blood vessels remained perfused (see
representative fluorescence angiographies taken 24 h post-
PDT in Figure 5c). Application of light alone did not induce a
vaso-occlusive effect (data not shown). At a higher dose
(100mg/embryo), all blood vessels and capillaries were
occluded within the illuminated area (Figure 5d).
Interestingly, the uptake of IAs in lining endothelial cells
was observed during and after PDT (Figure 5e), thereby also
leading to vascular damage (Figure 5f). Furthermore,
administration of IAs to the CAM grafted with human
ovarian A2780 tumors followed by PDT, resulted in
massive destruction of the tumor vasculature, already 24 h
post-treatment (Figures 5g and h). A second PDT treatment
was applied to the same tumors 24 h after the first treatment.
As visualized 24 h after the repeated PDT, almost all tumor
vasculature was destroyed and extensive vascular
dysfunction was observed, as revealed by the profound
leakage of FITC-dextran from the vasculature (Figures 5i and
j). This was also accompanied by massive destruction of the
ovarian tumor xenografts.
Discussion
Our current findings show that the achievement of an IAs-
dependent lysosomal photodestruction in tumor cells relies on
the striking sequestration of IAs in lysosomes. Several lines of
evidence support the differential compartmentalization of IAs
within lysosomes of tumor cells: (i) parental A549 and their
ABCG2-overexpressing MDR subline displayed co-localiza-
tion of C-1330 and the established lysosomal marker,
LysoTracker red; (ii) alkalinization of the acidic lysosomal
pH either with bafilomycin A1, a potent inhibitor of lysosomal
Hþ -ATPase, or ammonium chloride, an established
weak base (pKa¼ 9.25) lysosomotropic alkalinization agent,
resulted in the complete abrogation of lysosomal C-1330
accumulation. Previous studies have demonstrated that
treatment with bafilomycin A1 and ammonium chloride
increase the intralysosomal pH from 4–5 to 6.5–7.0.14 Hence,
the driving force for lysosomal sequestration of IAs is the
acidic lysosomal pH and the consequent irreversible entrap-
ment of lAs via protonation; and (iii) it is well documented 15,16
that hydrophobic weak base chemotherapeutics, such as
anthracyclines, Vinca alkaloids and other cytotoxic agents,
including acridone-based fluorescent compounds, the latter of
which are structurally related to IAs, markedly accumulate
within acidic lysosomes; a hallmark example is acridine
orange, a bona fide lysosomal marker widely used to
fluorescently label lysosomes in viable cells.17 Thus, the
organelle that predominantly compartmentalizes IAs in these
cancer cells is the lysosome. However, one cannot exclude
the possibility that alternative intracellular acidic vesicles such
Table 1 Growth inhibitory effects of various IAs on parental carcinoma cells and their MDR sublines
LD50 (nM) Fold Survival at 3000nMa (%)
Drug Cell line Control Illumination Sensitization Control Illumination Delta
C-1330 A549 5023±716 842±208 6 72±5 43±6 29
A549/K1.5 12269±1119 850±23 14 87±4 28±1 59
C-1379 A549 6349±867 199±31 32 60±1 2±0.3 58
A549/K1.5 15192±580 747±45 20 82±4 7±0.1 75
C-1375 A549 3054±260 212±29 14 50±3 3±2 47
A549/K1.5 5264±877 541±56 10 70±5 3±0.6 67
SW1573 5535±596 233±5 24 68±6 11±2 57
SW1573/2R160 4384±125 330±56 13 74±3 24±4 50
2008 3280±345 90±9 36 72±0.8 11±4 61
2008/MRP1 5115±889 101±0.1 51 80±2 13±3 67
Abbreviations: IAs, imidazoacridinones; LD50, 50% lethal dose; MDR, multidrug resistance
aConcentration chosen with the highest delta of % survival between illuminated and nonilluminated cells
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Figure 4 Treatment with the antimalarial chloroquine induces a marked increase in both the number and volume of lysosomes. A549 cells were seeded on glass cover
plates, allowed to attach and then exposed to 20 mM chloroquine for 24 (c) and 48 h (e), whereas control cells were not treated with chloroquine (a). The cytotoxic effect of
C-1330 to chloroquine-free control cells (b), cells exposed to 20mM chloroquine for 24 (d) or 48 h (f) in the absence or presence of illumination was determined by the XTT
assay as described in Figure 3 legend. The dose- and time-dependent effect of incubation with chloroquine on the increased number of lysosomes per A549 cell as compared
with nontreated cells was determined by fluorescence microscopy following staining with the viable lysosomal marker LysoTracker red (red fluorescence in chloroquine-treated
cells) (g) as detailed in Materials and Methods. Note that for the sake of quantification accuracy, the red lysosomal fluorescence of LysoTracker was converted to a yellow
fluorescence. Note the marked increase in the number and volume of lysosomes upon exposure of A549 cells to increasing concentrations of chloroquine as well as to
prolonged incubation times. Live detection of nuclei was achieved by staining with 1mg/ml Hoechst for 10 min before imaging
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as recycling endosomes, trans-Golgi network and secretory
vesicles could also contribute to sequestration of IAs.18
Our results suggest that an increased number of lysosomes
is a key determinant of cell defense and consequent drug
resistance against hydrophobic weak base cytotoxic agents
including IAs that may reach their cellular target, topoisome-
rase II and DNA in the case of IAs. First, ABCG2-over-
expressing A549/K1.5 cells that displayed a marked increase
in the number of lysosomes were 2.4-fold more resistant to
C-1330 and C-1379, both of which are not recognized as
drug efflux substrates by ABCG2. Second, the dramatic
chloroquine dose-dependent induction of increased lysosome
volume and number in parental A549 cells resulted in a
consistent increase of 3–7-fold in C-1330-resistance. Hence,
it is likely that epithelial and endothelial cells exposed to body
fluids containing various toxicants have evolved to acquire
larger number of lysosomes as means of cell defense against
stress cues and cytotoxic agents including lipid-soluble weak
base cytotoxins.19–21 Thus, as MDR cells are known to
contain an increased number of lysosomes per cell, targeting
MDR cells via lysosomal photodestruction using weak base
photosenstizers may be readily seen as a pharmacological
Achilles heel, and thus used as a Trojan horse approach to
eradicate MDR tumor cells.
The following evidence supports the choice of targeting
MDR cancer cells via IAs-dependent lysosomal photodestruc-
tion: (i) the luminal pH of lysosomes of various MDR tumor
cells was found to be markedly more acidic than their parental
counterparts, hence increasing the pH gradient between the
cytoplasm and lysosomes;22,23 it is possible that the various
Figure 5 PDT after i.v. IA injection in the CAM vasculature and in tumor grafted CAMs. (a) Emission and excitation spectra of C-1379. (b) IA fluorescence angiography
before IA-PDT (1 mg/embryo, lex¼ 420±20 nm). The bar in panel b denotes 500mm. (c) FITC-dextran angiography (lex¼ 470±20 nm, lem 4520 nm), 24 h after PDT
(light dose 20 J/cm2, irradiance 70 mW/cm2). (d) IA fluorescence angiography taken before IA-PDT (100mg/embryo, (lex¼ 420±20 nm), right after (e; inset shows the
magnification of IA in the endothelial lining after PDT) and 24 h (f) after PDT (light dose 20 J/cm2, irradiance 270 mW/cm2) visualized by FITC-dextran angiography
(lex¼ 470±20 nm, lem 4520 nm). Tumor grafted CAMs, 24 h post IA-PDT of ovarian carcinoma on the CAM shown by fluorescence angiography (g, FITC-dextran
angiography, lex¼ 470±20 nm, lem4520 nm) and white light camera (h). The same tumor 48 h after the second IA-PDT visualized by FITC-dextran angiography (i) and
white light camera (j). Black zones represent avascular areas
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MDR cell lines studied here also harbor more acidified
lysosomes than their parental cells. This would result in an
increased capacity of these MDR cells to sequester hydro-
phobic weak base cytotoxic agents including IAs within
lysosomes; (ii) it has been shown that various MDR
tumor cells display a more basic cytoplasmic pH than their
drug-sensitive parental counterparts and nonmalignant
cells.18,22,23 Consequently, the pH gradient between the
cytoplasm and lysosomes will further increase, hence enhan-
cing the capacity of lysosomes to concentrate hydrophobic
weak base cytotoxic agents. Consistently, the MDR tumor
cells employed here could comply with this increased DpH
between the lysosome and the cytoplasm, thereby further
enhancing the capacity of lysosomes to highly sequester IAs.
These predictions that the MDR cells we employed here
possess lysosomes that are more acidic and presumably
have a more basic cytoplasmic pH are supported by the fact
that apart from the increased number of lysosomes in A549/
K1.5 cells, each lysosome of these MDR cells displayed a
markedly increased accumulation of the fluorescent IAs,
when compared with the rather faint fluorescence signal
emitted from parental cell lysosomes; and (iii) one of the
hallmarks of malignant tumors and metastatic cancers is
acidosis of their tumor microenvironment;24 this is attributable
to lactic acid production via anaerobic glycolysis of cancer
cells (known as the Warburg phenomenon) that proliferate
under hypoxic conditions. Hence, this acidosis of the tumor
microenvironment implies that hydrophobic weak base
chemotherapeutics would preferentially accumulate in solid
tumors than in healthy tissues. This would present an
excellent opportunity for intratumoral sequestration, which
could be then followed by PDT, ROS generation and tumor
destruction. This should result in enhanced therapeutic
efficacy in the absence of severe damage to healthy tissues.
In fact, this has been one of the major underlying principles of
the selectivity of the concentration of the cytotoxic photo-
sensitizer effect of PDT agents used against malignant
cancers.25
Our findings suggest that the mechanism underlying the
damage inflicted by illumination, rapid lysosome rupture and
cell death is mediated through rapid production of ROS. First,
using established methodologies we showed that photoexci-
tation of IAs results in the formation of singlet oxygen and
superoxide anion. Second, the presumed mediation of cell kill
by ROS in our IA-loaded MDR cells undergoing lysosomal
photodestruction, is in accord with the widely accepted
mechanism of cytotoxicity of various photosensitizers
used in PDT including protoporphyrins; upon illumination,
these photosenstizers undergo fluorescence excitation
(i.e., from the singlet excited state), and/or transferring their
excitation (energy) to the triplet state molecular oxygen via
intersystem crossing. The latter undergoes collisional energy
transfer with ground state O2
3S to yield reactive O2
1D. Other
ROS can be also produced by the excited photosensitizer.26
Recent studies have determined that ROS production in a
PDT scheme using photoexcited protoporphyrin IX induced
an essentially instantaneous production of ROS with a
remarkable time rate constant of 0.0044min1.27 Thus, the
rapid lysosomal photodestruction in our MDR tumor cells is
consistent with this rate constant of ROS production.
Singlet oxygen radicals and ROS are extremely detrimental
to biomolecules such as proteins, nucleic acids and
biomembranes and result in rapid cell death. Hence, the
abrupt lysis of IA-loaded lysosomes upon photoexcitation is
consistent with the rapid generation of ROS. The consequent
intracellular rupture of lysosomes with the abrupt introduction
of their harmful highly acidic content containing a spectrum of
extremely potent hydrolytic enzymes would certainly lead to
rapid digestion of polypeptides, nucleic acids and biomem-
branes and consequent cell lysis. This is supported by our
Crystal Violet staining of monolayer cells undergoing lysoso-
mal photodestruction in which complete cell lysis occurred
with residual cytoskeletal scaffolds. In summary, the differ-
ential quantitative retention of the IAs photosensitizers in
lysosomes in MDR cells could be used as an Achilles heel
strategy to eradicate MDR cells. Interestingly, despite the
photoexcitation, the harsh acidic pH and ample hydrolytic
activities of the lysosomes, IAs, unlike many PDT agents, did
not undergo photolysis and apparently retained their structure
and function as they readily bind to DNA upon lysosomal
rupture. This may be an added value in inflicting a cytotoxic
effect upon neighbor nonilluminated malignant cells, tumor
microenvironment and vasculature.
Materials and Methods
Chemicals. LysoTracker red DND99 and MitoTracker red CMXRos were
purchased from Invitrogen (Carlsbad, CA, USA). Ammonium chloride, acridine
orange, Crystal Violet and chloroquine were from Sigma-Aldrich (St. Louis, MO,
USA). Bafilomycin A1 was purchased from Enzo Life Science (Farmingdale, NY,
USA). IAs were synthesized by Drs. M Cholody, B Horowska and M Konieczny in
the Department of Pharmaceutical Technology and Biochemistry, Gdansk
University of Technology, Gdansk, Poland.
Cell culture. Non-small-cell lung cancer A549 cells and their ABCG2-
overexpressing A549/K1.5 subline, ovarian carcinoma 2008 cells and their stable
MRP1 transfectant 2008/MRP1, non-small lung cancer cell line SW1573 and its ABCB1-
overexpressing subline SW1573/2R160 were maintained in RPMI-1640 medium (Gibco,
Paisley, UK) supplemented with 10% fetal bovine serum, 2 mM glutamine, 100mg/ml
penicillin and streptomycin (Biological Industries, Beth-Haemek, Israel) in a humid
atmosphere containing 5% CO2 at 371C. A549/K1.5 and SW1573/2R160 cells were
grown in medium containing 1.5mM C-1305 28 and 100 nM doxorubicin, respectively.
Cells were cultured in drug-free conditions for a week before any analysis.
Live cell imaging and quantification of lysosomes. A549 and A549/
K1.5 cells were grown for 24 h in 35 mm FluoroDish (World Precision Instruments,
Sarasota, FL, USA). For C-1330 localization studies, cells were viably stained with
10mM C-1330 for 30 min along with either 100 nM LysoTracker red or 100 nM
MitoTracker red for 1 h at 371C. The established viable lysosomal marker
LysoTracker red was used to quantify the number/volume of lysosomes per cell in
parental tumor cells and their MDR sublines overexpressing specific MDR efflux
transporters of the ABC superfamily. Cellular LysoTracker red fluorescence was
followed with a Zeiss Axiovert 200 inverted fluorescence microscope (Carl Zeiss,
Oberkochen, Germany) equipped with a digital camera using a red Cye 3 filter
(lex¼ 545 nm and lem¼ 605 nm). Quantification of red fluorescence of lysosomes
per cell was undertaken by evaluating at least 25 LysoTracker red-stained cells in
each of at least three independent experiments using the EZ-Quant statistical
analysis software (version 1105). Inverted fluorescence microscopy analysis of
viable fluorescent cells was performed at a magnification of  630.
Before fluorescence imaging, cells were incubated in medium containing 2mg/ml
Hoechst 33342 for 10 min. For nuclear staining, A549/K1.5 cells were incubated for
1 h with Hoechst 33342 and 10mM fumitremorgin C (FTC) to prevent efflux of the
DNA dye by ABCG2. Live cell imaging was performed using a Zeiss Axiovert 200
inverted fluorescent microscope (Carl Zeiss).
Chloroquine treatment. A549 cells were seeded in 96-well plates at 500 or
1000 cells/well (for 24 h or 48 h treatment, respectively; 0.1 ml medium/well).
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Following an overnight incubation, chloroquine was added for 24 h (20, 50 and
100mM) or 48 h (20mM). For cytotoxicity assays, C-1330 concentrations ranging
from 10 nM to 100 mM were added for two additional hours. For viable fluorescent
labeling of lysosomes and nuclei, LysoTracker red DND 99 (100 nM) was added for
1 h before fluorescence imaging, following which Hoechst 33342 (2mg/ml) was
added 10 min before imaging. Cells were first analyzed with a Zeiss Axiovert
200 inverted fluorescence microscope (Carl Zeiss) equipped with a digital camera
and then illuminated using a GFP þ DsRed filter (lex¼ 470 nm; lem¼ 512 nm
and 630 nm; this is a long pass filter which transmits longer wavelengths over a wide
spectrum). LysoTracker Red and MitoTracker Red CMXRos were followed using a
red filter Cye 3 (lex¼ 545 nm and lem¼ 605 nm), whereas a DAPI filter
(lex¼ 365 nm and lem¼ 445±50 nm) was used to follow nuclear staining with
Hoechst 33342. Light intensity was maintained at 12.5% of the maximum.
Light intensity in the illuminated cell monolayer zone was B3 W/m2 and the light
dosage for 30 s was 90 J/m2. The magnification used was  630.
Crystal Violet staining. Cells were grown to confluence on glass bottom
plates and incubated with 10mM C-1330 for 30 min. Following medium refreshment,
plates were exposed to 1 min constant excitation at 470 nm using a Zeiss inverted
fluorescence microscope. Cells displaying lysosomal photodestruction were further
incubated for 48 h at 371C, then washed twice with PBS, fixed with 70% and stained
with a dilute (1:5) Crystal Violet solution in PBS. Stained monolayer cells were then
examined and photographed using a Leica M80 binocular at a  8 magnification
(Leica Microsystems GmbH, Wetzlar, Germany).
Cytotoxicity assays. Cells were seeded in 96-well plates (2 104 cells in
90ml growth medium/well), incubated for 24 h and exposed to increasing
concentrations of IAs. Following 2 h incubation, the drug-containing medium was
replaced by drug-free medium and cells were placed on an illuminator plate (Model
460 thin line series, S&S X-Ray Products Inc., Brooklyn, NY, USA) for 1 h, hence
achieving a light dose of 5 J/cm2. Plates were then further incubated for 24 h. Cell
viability was determined using the Cell Proliferation Kit (XTT) (Biological Industries).
Drug concentrations required to inhibit cell growth by 50% (IC50) in the absence or
presence of illumination, were determined from the cell survival curves. Results
presented are means of at least three independent experiments.
Spectroscopy assessment of IAs. C-1375 and C-1379 were dissolved in
DMSO (Sigma-Aldrich) and diluted in 0.9% NaCl. Absorption spectra were recorded
with a two-beam Varian Cary UV-Vis-NIR 500 Scan spectrophotometer in 1-cm long
quartz cuvettes (Suprasil, Hellma, Mu¨llheim, Germany) in the range of 350 to
750 nm with an average scan speed of 600 nm/min at room temperature. Steady-
state luminescence spectra were recorded with a luminescence spectrometer
(Perkin-Elmer, model LS50B, Wellesley, MA, USA).
Texas red-phalloidin staining. A549 cells were grown on coverslips in
24-well plates until confluence was reached. Cells were then incubated with 10 mM
C-1330 for 30 min and exposed to light for 1 min, resulting in lysosomal
photodestruction. Control cells were loaded with C-1330 but were not illuminated.
C1330-loaded cells were either fixed and stained with Texas Red-X-Phalloidin (Life
Technologies, Carlsbad, CA, USA) with no illumination or stained with Texas Red-X-
Phalloidin 2 h after light-induced lysosomal photodestruction. Cells were then
washed twice with PBS and fixed by adding 4% formaldehyde for 10 min in room
temperature. Following two additional washes with PBS, 0.1% Triton X-100 was
added for 10 min and then washed twice to remove Triton X-100. Blocking was then
achieved using a solution of 20% skim milk and 2.5% fetal calf serum for 20 min. At
this stage, 5ml of Texas Red–X phalloidin stock solution was added into 0.2 ml of
PBS and incubated protected from light for 20 min. The samples were finally rinsed
to remove excess Texas Red-X Phalloidin. Coverslips were removed gently from
wells and attached onto slides using Fluoromount-G. Fluorescent cells were
analyzed by a fluorescence microscope at lex¼ 545 nm and lem¼ 605 nm.
Detection of superoxide anion and singlet oxygen. Photosensitized
formation of superoxide anion was detected by EPR-spin trapping using DMPO as a
spin trap, as described previously.29,30 IAs solutions containing 0.1 M DMPO
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany) in DMSO/H2O (9:1) were
illuminated in a 0.25-mm quartz cell within the resonant cavity of a Bruker EMEX-AA
EPR spectrometer (Bruker BioSpin, Rheinstetten, Germany) with 400–490 nm light
derived from a Cermax PE300CE-13FM 300 W lamp in air-cooled housing (Perkin
Elmer). This light source was equipped with the necessary combination of cutoff and
band-pass filters. Relative yields of the photo-formation of superoxide anion by IAs in
the presence or absence of NADH, used as an auxiliary electron donor, were
determined by comparing rates of the accumulation of DMPO-OOH determined for IAs
and for riboflavin with and without EDTA. Quantum yields for singlet oxygen
photogeneration by IAs were determined relative to that for Rose Bengal (RB) by
measuring time-resolved luminescence intensity in DMSO or acetonitrile solutions at
1270 nm, after excitation of the compounds or RB at 355 nm with microjoule 750 ps
pulses generated by a microchip Nd:YAG laser (Pulselas-P-1064-FC, Alphalas GmbH,
Goettingen, Germany), operating with 2–10 kHz repetition rate. Near-infrared
luminescence was measured perpendicularly to the excitation beam in a photon-
counting mode 31 using a thermoelectric cooled NIR PMT module (model H10330-45,
Hamamatsu, Shizuoka, Japan) equipped with a 1100-nm cutoff filter and additional
selected narrow-band filters (NB series, NDC Infrared Engineering Ltd, Maldon, UK).
Data were collected using a computer-mounted PCI-board multichannel scaler
(NanoHarp 250, PicoQuant GmbH, Berlin, Germany).
In vivo PDT with IAs using the CAM model. Fertilized chicken eggs
(Animalco AG, Staufen, Switzerland) were incubated in a hatching incubator (65%
humidity, 371C) equipped with an automatic rotator (Savimat, Chauffry, France) as
described previously.32 Briefly, on embryo development day 11 (EDD 11), the hole
in the shell above the air pouch of the egg (made on EDD 3) was extended to a
diameter of B3 cm in order to provide better access to the CAM for the
experiments. Eggs were placed under an epi-fluorescence microscope (Eclipse 600
FN, Nikon, Egg, Zurich, Switzerland). Subsequently, 100ml of IAs (C-1375 or
C-1379) at doses of 1mg/embryo or 100mg/embryo were administered into the main
vessel of the CAM through a 33-gauge needle fitted to a 100ml syringe (Hamilton,
Reno, NV, USA). One minute later, the 0.02 cm2 area of the CAM was irradiated with
a light dose of 20 J/cm2 (lex¼ 420 nm), irradiance of 70 or 270 mW/cm2. The site was
photographed before and after the irradiation. Subsequently, the egg opening was
sealed with Parafilm (Pechiney, Menasha, WI, USA) and the embryo was incubated
for 24 h. The PDT-induced damage was assessed by fluorescence angiography after
i.v. injection of FITC-dextran (20 kDa, 25 mg/ml; lex¼ 470 nm and lem¼ 520 nm)
and India ink (30ml/embryo) into the extra-embryonic cavity as previously described.33
IA treatment was performed with five eggs.
Tumor xenografts on the CAM and IA treatment with PDT. Human
A2780 ovarian carcinoma cells were used to establish tumor xenografts in the CAM.
Tumor cells were suspended in medium containing 20% methocel (Sigma-Aldrich),
and 50ml drops (1 106 cells/drop) were dispensed on the internal part of the lid of
a petri dish. After 24 h, spheroids were harvested and placed on the CAM (EDD 7).
At EDD 11, C-1375 and C-1379 were injected i.v. at a dose of 12 mg/embryo. PDT of
tumor xenografts was performed 1 min later (lex¼ 420 nm; light dose 34 J/cm2;
irradiance 70 mW/cm2). The PDT procedure was repeated 24 h later. Tumors
were visualized by standard white light camera and subsequently by
FITC-dextran angiography, 24 and 72 h after the first PDT treatment.
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